Effect of Some Drugs on Liver Fibrosis

Sherief Abd-Elsalam

Status and phase: Enrolling; Phase 3

Conditions: Liver Fibroses

Treatments: Drug: Ramipril; Drug: Candesartan

Study type: Interventional

Funder types: Other

Identifiers

NCT03770936

liver fibrosis

Details and patient eligibility

About

Effect of Some Drugs on Liver Fibrosis

Full description

The study aimed at evaluating the effect of Some Drugs on Liver Fibrosis

Enrollment: 45 estimated patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• chronic hepatitis C

Exclusion criteria

• Acute hepatitis
• Thalassemia

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

45 participants in 3 patient groups

Control group

No Intervention group

Description:

No intervention

Candesartan

Active Comparator group

Description:

Candesartan 8 mg/day

Treatment:

Drug: Candesartan

Ramipril

Active Comparator group

Description:

Ramipril 1.25 mg/day

Treatment:

Drug: Ramipril